HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Social media and physicians: A good pair, but guidelines for use needed
-
- Brentuximab vedotin produced durable objective responses in relapsed CD30-positive lymphomas
- Cardiovascular, renal diseases present complications for clinicians treating HIV
- Combined endosonography, surgical staging had best sensitivity for operable NSCLC
- Deceptive presentation of metastatic lobular breast carcinoma Munir Ghesani, MD, FACNM; Rami Daya, MD; Iwao Tanaka, MD; Irene Dy, MD
- Degarelix had similar cardiovascular safety profile as leuprolide in prostate cancer
- Every-other-day treatment with G-CSF may be cost effective in NHL patients
- Gene expression profiling advances in multiple myeloma Ronald A. Sacher, MD
- High doses of recombinant-activated Factor VII associated with increased risk for arterial thromboembolic events
-
- Hydroxyurea may reduce pain-related complications of sickle cell anemia
- DNMT3A associated with poor outcomes in AML
- Medical societies, experts dismiss radiation exposure from radioiodine as a public health concern
- More people lack continuous health care coverage; delay needed exams
- Racial disparities in lung cancer rates still exist in the US
- Study notes that doctors find Medicare reimbursement inequitable, disagree on changes needed
- Howard Weinstein, MD, runs to raise funds for cancer research
- Severe pancytopenia a clue to Waldenström’s macroglobulinemia Amit Mehta, MD
-
- ULABTKA cream worsened symptoms of hand-foot syndrome